According to the three, all the appointments take effect from November 7 and will run for a minimum of three years.
Bank of America’s AI bull case on British semiconductor and software design company Arm is straightforward: The mechanics ...
Clinical Trials Arena on MSN
Imbria randomises first subject in Phase IIb trial of nHCM therapy
Imbria Pharmaceuticals has randomised the first participant in FORTITUDE HCM, a Phase IIb trial of ninerafaxstat in ...
The joint exercise, Tūhono Rangi, involves German military aircraft doing formation and low-altitude flights and deploying ...
Advances development of ninerafaxstat, a potential first-in-class therapy designed to improve cardiac energetics in patients with serious cardiovascular diseases Enrollment underway across U.S. sites ...
Three Late Breaking Science Presentations from MAPLE-HCM Provide Additional Data Including Responder Analyses, Patient Reported Outcomes, and Cardiac Biomarkers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback